Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on April 19, 2023. The company is incorporated in North Carolina and is designated as an emerging growth company. The report addresses a specific corporate event regarding its preferred stockholders.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to a dividend declaration:
- Dividend Amount: $0.0667 per share.
- Security Class: 8.0% Series A Cumulative Convertible Preferred Stock (Symbol: YCBDpA).
- Record Date: May 1, 2023.
- Payment Date: May 15, 2023.
Material Changes
The filing reports the declaration of a monthly cash dividend for the Series A Convertible Preferred Stock. No other material changes to the company's financial condition or operations are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure of the dividend obligation. The declaration was authorized by T. Ronan Kennedy, Interim CEO and Chief Financial Officer.
Investor Verification Checklist
- Verify the record date (May 1, 2023) to confirm eligibility for the $0.0667 per share dividend.
- Confirm the payment date of May 15, 2023, for cash flow planning.
- Review the terms of the 8.0% Series A Cumulative Convertible Preferred Stock to understand conversion rights and cumulative dividend obligations.
- Note that this filing does not contain updated revenue or earnings data; refer to the most recent 10-Q or 10-K for operational metrics.